Projected Outcomes of Reduced-Biopsy Management of Grade Group 1 Prostate Cancer: Implications for Relabeling.
Zhao Y, Gulati R, Yang Z, Newcomb L, Zheng Y, Zhu K, Liu M, Heijnsdijk EAM, Haffner MC, Cooperberg M, Eggener SE, De Marzo AM, Kibel AS, Rizopoulos D, Hall IJ, Etzioni R.
Zhao Y, et al. Among authors: zheng y.
J Natl Cancer Inst. 2024 Nov 20:djae296. doi: 10.1093/jnci/djae296. Online ahead of print.
J Natl Cancer Inst. 2024.
PMID: 39565901